Simmons Hanly Conroy Again Named Among Best St. Louis Law Firms

St. Louis Small Business Monthly readers voted the firm among the best law firms for the fourth consecutive year

ST LOUIS – Simmons Hanly Conroy LLC, a national litigation firm focused on complex litigation matters for individuals and businesses, has again been voted as one of the best law firms in St. Louis by readers of the St. Louis Small Business Monthly. Unlike most traditional law firms, the firm offers businesses and entrepreneurs legal representation on a contingency-fee basis.

SHC Building - DefaultManaging Shareholder Michael Angelides extended his thanks to those who nominated the firm for inclusion in the June 2015 “Best in Business” Law Firm listing. More than 200 nominations were received, and only 29 law firms made the list.

“We appreciate the honor awarded to us by St. Louis Small Business Monthly readers,” he said. “As a firm dedicated to the welfare of our clients, employees and local community, we want to thank you for this recognition.”

Every edition of the St. Louis Small Business Monthly polls its readers about the best business in a particular industry that helps other businesses. Earlier this year, readers were asked to list the top law firms. This is the fourth year Simmons Hanly Conroy has made the finalists’ list.

The firm focuses on complex litigation for business, including traditional commercial litigation matters such as breach of contract, unfair competition and other business torts.

The “Best in Business” Law Firm list appears in the June 2015 edition of the magazine. Companies who made the final list will be honored during the Small Business Monthly’s annual Business Expo in October.

SIMMONS HANLY CONROY LLC is a leading national law firm in complex litigation and represents clients throughout the country on issues involving consumer protection rights, class actions and contingent-fee commercial litigation. With 70 attorneys in five offices across the country, the firm is dedicated to its clients and has pledged nearly $20 million to cancer research. Additionally, the firm focuses on intellectual property infringement, pharmaceutical injury litigation and toxic exposure. For more information, visit